Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · IEX Real-Time Price · USD
2.81 0.10 (3.69%)
Oct 27, 2021 10:02 AM EDT - Market open
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
| Year | 2020 |
|---|---|
| Selling, General & Admin | 0.04 |
| Operating Expenses | 0.04 |
| Operating Income | -0.04 |
| Pretax Income | -0.04 |
| Net Income | -0.04 |
| Net Income Common | -0.04 |
| Shares Outstanding (Basic) | 7 |
| Shares Outstanding (Diluted) | 7 |
| Free Cash Flow Per Share | -0.01 |
| EBITDA | -0.04 |
| EBIT | -0.04 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).